ICD-9 Codes and Surveillance for Clostridium difficile–associated Disease

by Erik R. Dubberke, Kimberly Reske, L. Clifford McDonald, Victoria Fraser
Published 2006-10-01

Comparing intervention strategies for reducing Clostridioides difficile transmission in acute healthcare settings: an agent-based modeling study

by Brittany Stephenson, Cristina Lanzas, Suzanne Lenhart, Eduardo Ponce, Jason Bintz, Erik R. Dubberke, Judy Day
Published 2020-10-01

Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings

by David P. Durham, Margaret A. Olsen, Erik R. Dubberke, Alison P. Galvani, Jeffrey P. Townsend
Published 2016-04-01

Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis.

by Erik R Dubberke, Margaret A Olsen, Dustin Stwalley, Ciarán P Kelly, Dale N Gerding, Yinong Young-Xu, Cedric Mahé
Published 2016-01-01

Attributable Outcomes of Endemic Clostridium difficile–associated Disease in Nonsurgical Patients

by Erik R. Dubberke, Anne M. Butler, Kimberly A. Reske, Denis Agniel, Margaret A. Olsen, Gina D’Angelo, L. Clifford McDonald, Victoria J. Fraser
Published 2008-07-01

Pathogenicity Locus, Core Genome, and Accessory Gene Contributions to Clostridium difficile Virulence

by Brittany B. Lewis, Rebecca A. Carter, Lilan Ling, Ingrid Leiner, Ying Taur, Mini Kamboj, Erik R. Dubberke, Joao Xavier, Eric G. Pamer, Jimmy D. Ballard
Published 2017-08-01

Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study

by Amy Langdon, Drew J. Schwartz, Christopher Bulow, Xiaoqing Sun, Tiffany Hink, Kimberly A. Reske, Courtney Jones, Carey-Ann D. Burnham, Erik R. Dubberke, Gautam Dantas, for the CDC Prevention Epicenter Program
Published 2021-02-01

Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients

by Skye R. S. Fishbein, Tiffany Hink, Kimberly A. Reske, Candice Cass, Emily Struttmann, Zainab Hassan Iqbal, Sondra Seiler, Jennie H. Kwon, Carey-Ann D. Burnham, Gautam Dantas, Erik R. Dubberke
Published 2021-02-01

Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential

by Christopher Bulow, Amy Langdon, Tiffany Hink, Meghan Wallace, Kimberly A. Reske, Sanket Patel, Xiaoqing Sun, Sondra Seiler, Susan Jones, Jennie H. Kwon, Carey-Ann D. Burnham, Gautam Dantas, Erik R. Dubberke
Published 2018-11-01

Comparative Genomics of Antibiotic-Resistant Uropathogens Implicates Three Routes for Recurrence of Urinary Tract Infections

by Robert Thänert, Kimberly A. Reske, Tiffany Hink, Meghan A. Wallace, Bin Wang, Drew J. Schwartz, Sondra Seiler, Candice Cass, Carey-Ann D. Burnham, Erik R. Dubberke, Jennie H. Kwon, Gautam Dantas
Published 2019-08-01

Impact of investigational microbiota therapeutic RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trial

by Suryang Kwak, JooHee Choi, Tiffany Hink, Kimberly A. Reske, Kenneth Blount, Courtney Jones, Margaret H. Bost, Xiaoqing Sun, Carey-Ann D. Burnham, Erik R. Dubberke, Gautam Dantas, for the CDC Prevention Epicenter Program
Published 2020-08-01